|本期目录/Table of Contents|

[1]郝坤艳,杨玄子,何 锐,等.肝衰竭患者肾功能评估策略的优化分析[J].传染病信息,2019,04:203-207214.
 HAO Kun-yan,YANG Xuan-zi,HE Rui,et al.Analysis of optimal strategies for assessment of renal function in patients with liver failure[J].Infectious Disease Information,2019,04:203-207214.
点击复制

肝衰竭患者肾功能评估策略的优化分析(PDF)

《传染病信息》[ISSN:1007-8134/CN:11-3886/R]

期数:
2019年04期
页码:
203-207214
栏目:
论 著
出版日期:
2019-09-12

文章信息/Info

Title:
Analysis of optimal strategies for assessment of renal function in patients with liver failure
文章编号:
   1007-8134(2019)03-0203-06
作者:
郝坤艳杨玄子何 锐王寿明于乐成
210002南京,东部战区总医院,南京中医药大学附属八一医院,全军肝病中心(郝坤艳、杨玄子、王寿明、于乐成);243031,马鞍山市第四人民医院肝病科(何锐)前两位作者对本文有同等贡献,均为第一作者
Author(s):
HAO Kun-yan YANG Xuan-zi HE Rui WANG Shou-ming YU Yue-cheng*
Liver Disease Center, General Hospital of Eastern Theater Command, Bayi Hospital Affiliated to Nanjing University of Chinese Medicine, Nanjing 210002, China HAO Kun-yan and YANG Xuan-zi are the first authors who contributed equally to the article
关键词:
肝衰竭肾功能不全血清肌酐血清胱抑素估算肾小球滤过率优选
Keywords:
liver failure renal dysfunction serum creatinine serum cystain C evaluated glomerular filtration rate optimization
分类号:
R692;R575.3    
DOI:
10.3969/j.issn.1007-8134.2019.03.003
文献标识码:
A
摘要:
目的 通过比较急性 /亚急性肝衰竭和慢加急性 /亚急性肝衰竭患者血清肌酐( serum creatinine, Scr)、胱抑素 C(cystatin C, Cyc)及基于多种公式计算的估算肾小球滤过率(estimated glomerular .ltration rate, eGFR),优化筛选适合此类患者的肾功能评估指标。方法 回顾性分析 2011年 1月—2018年 5月符合急性 /亚急性肝衰竭(Ⅰ组)或慢加急性 /亚急性肝衰竭(Ⅱ组,又分Ⅱ A、Ⅱ B、Ⅱ C组)诊断标准的 210例肝衰竭患者的临床资料,以 213例健康体检者为对照组,比较各组 Scr、Cyc及 9种 eGFR计算公式在肝衰竭患者及对照组的组间和组内差异。结果 Ⅱ组 Scr和 Cyc水平显著高于对照组( P均< 0.05);I组 Cyc水平显著高于对照组( P< 0.05),而 2组间 Scr水平比较,差异无统计学意义( P> 0.05)。I、II组内 eGFR4、eGFR5、eGFR10及 eGFR7的异常率最低值分别为 100%、80.00%、96.44%及 60.00%,对照组内的异常率最低值分别为 100%、25.82%、70.89%及 10.33%。与 eGFR1和 eGFR2相比, eGFR3的假正常率最高,最高达 48.81%。血清 Cyc及 Scr均正常时,eGFR6假降低率较其他 eGFR均高,最高达 65.24%。结论 对于肝衰竭患者的肾功能评估,血清 Cyc较 Scr更为可靠。各种 eGFR公式中,以基于 Scr联合 Cyc的公式 eGFR11和基于 Scr的 eGFR2及 eGFR1较为合适,尤其是 eGFR11。  
Abstract:
Objective To optimize the rational indicators for the assessment of renal dysfunction in patients with acute/sub-acute liver failure (ALF/SALF) or acute/sub-acute on chronic liver failure (AOCLF/SAOCLF) by comparing serum creatinine (Scr), cystatin C (Cyc) and formula-based estimated glomerular filtration rates (eGFR). Methods Two hundred and ten patients with liver failure hospitalizedbetween January 2011 and May 2018 who met the diagnosis criteria of ALF/SALF and AOCLF/SAOCLF were divided into group I(ALF/SALF) and group II (AOCLF/SAOCLF, including IIA, IIB and IIC), while 213 healthy examinee were selected as control group. The intergroup and intragroup difference of serum levels of Scr and Cyc, and 9 eGFR formula were compared. Results Scr and Cyc levels were significantly higher in group II than those in control group (P< 0.05). Cyc levels were significantly higher in group I than that in control group (P< 0.05), while Scr levels had no statistical significance between 2 groups. The lowest abnormality rates of eGFR4, eGFR5,eGFR10 and eGFR7 were 100%, 80.00%, 96.44% and 60.00% in group I and II, and 100%, 25.82%, 70.89% and 10.33% in control group, respectively. Compared to eGFR1 and eGFR2, eGFR3 had the highest false negative rate which reached 48.81%. When both Cyc and Scr levels were normal, eGFR6 had a higher false negative rate than other eGFRs, which reached 65.24%. Conclusions For assessment of renal dysfunction in patients with liver failure, serum Cyc is more reliable than Scr. Among various eGFR formula, formula eGFR11 based on the levels of Scr and Cyc, formula eGFR2 and eGFR1 based on the levels of Scr are the optimal formula, especially formula eGFR11.     

参考文献/References


[1] Low G, Alexander GJ, Lomas DJ. Hepatorenal syndrome: actiology, diagnosis, and treatment[J]. Gastroenterol Res Pract, 2015, 2015:207012.
[2] Tandon P, Garcia-Tsao G. Renal dysfunction is the most important independent predictor of omortality in cirrhotic patients withspontaneous bacterial peritonitis[J]. Clin Gastroenterol Hepatol, 2011, 9(3):260-265.
[3] Belcher JM, Garcia-Tsao G, Sanyal AJ, et al. Association of AKI with mortality and complications in hospitalized patients withcirrhosis[J]. Hepatology, 2013, 57(2):753-762.
[4] 中华医学会肝病学分会 . 肝硬化腹水及相关并发症的诊疗指南[J]. 传染病信息,2017,30(5):158-174.
[5] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组 . 肝衰竭诊治指南[J]. 临床肝胆病杂志,2019,35(1):38-44.
[6] Myers GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: a report from theLaboratory Working Group of the National Kidney DiseaseEducation Program[J]. Clin Chem, 2006, 52(1):5-18.
[7] Levey AS, Stevens LA, Sehmid CH, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150(9):604-612.
[8] Stevens LA, Claybon MA, Schmid CH, et al. Evaluation of the CKD-EPI equations in multiple races and ethnicities[J]. KidneyInt, 2011, 79(5):555-562.
[9] Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerularfiltration rate from serum creatinine and cystatin C[J]. N Enql J Med, 2012, 367(1):20-29.
[10] Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR usingserum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD[J]. Am J Kidney Dis, 2008, 51(3):395-406.
[11] 全国课题协作组 . MDRD方程在我国慢性肾脏病患者中的改良和评估[J]. 中国肾脏病杂志,2006,22(10):589-595.
[12] 吴锡信 . 基于血清胱抑素 C的成年中国人肾小球滤过率估算公式临床对比研究[J]. 中国危重病急救医学,2012, 24(9):530-533.
[13] Ma YC, Zuo L, Chen JH, et al. Improved GFR estimation bycombined creatinine and cystatin C measurements[J]. Kidney Int, 2007, 72(12):1535-1542.
[14] 李红艳 . ROC曲线评价血清胱抑素 C对早期肾功能损伤的临床诊断价值[J]. 中国实验诊断学,2017,21(6):958-960.
[15] Wei L, Ye X. Diagnostic accuracy of serum cystatin C in chronickidney disease: a meta-analysis[J]. Clin Nephrol, 2015, 84(2):86.
[16] 臧红,郭建民,辛红霞,等 . 血清胱抑素 C在 HBV相关慢加急性肝衰竭患者中的临床意义[J]. 中华试验和临床病毒学杂志,2017,31(4):338-342.
[17] Nadim MK, Kellum JA, Davenport A, et al. Hepatorenal syndrome: The 8th international consensus conference of the acute dialysisquality initiative(ADQI) group[J]. Crit Care, 2012, 16(1):R23.
[18] Wan ZH, Wang JJ, You SL, et al. Cystatin is biomarker forpredicting acute kidney injury in patients with acute-on-chronicliver failure[J]. World Gastroenterol, 2013, 19(48):9432-9438.

备注/Memo

备注/Memo:
[基金项目] 原南京军区十一五医药科技重点项目(09Z011)
[作者单位] 210002南京,东部战区总医院,南京中医药大学附属八一医院,全军肝病中心(郝坤艳、杨玄子、王寿明、于乐成);243031,马鞍山市第四人民医院肝病科(何锐)前两位作者对本文有同等贡献,均为第一作者
[通信作者] 于乐成,E-mail: gslsycy@163.com
更新日期/Last Update: 2019-07-12